178 filings
8-K
ICPT
Intercept Pharmaceuticals, Inc.
8 Nov 23
Entry into a Material Definitive Agreement
4:44pm
8-K
ICPT
Intercept Pharmaceuticals, Inc.
26 Sep 23
Entry into a Material Definitive Agreement
8:28am
8-K
ICPT
Intercept Pharmaceuticals, Inc.
2 Aug 23
Intercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updates
7:05am
8-K
ICPT
Intercept Pharmaceuticals, Inc.
23 Jun 23
Intercept Announces Restructuring to Strengthen Focus on Rare and Serious Liver Diseases and Significantly Reduce Operating Expenses
6:35am
8-K
ICPT
Intercept Pharmaceuticals, Inc.
22 Jun 23
Intercept Receives Complete Response Letter from FDA for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH
8:50pm
8-K
y3suel5ww
25 May 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
ecr1r 0aqy
19 May 23
Intercept Announces Outcome of FDA Advisory Committee Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH
7:27pm
8-K
5ri 2oiqvu4dq37
17 May 23
Entry into a Material Definitive Agreement
5:43pm
8-K
5t1 c75te
27 Apr 23
Intercept Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Update on Commercial Launch Strategy for NASH
7:05am
8-K
lmpgtcd ygrffo
24 Mar 23
Entry into a Material Definitive Agreement
5:18pm
8-K
x56n79cpc
2 Mar 23
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates; Issues 2023 Financial Guidance
7:05am
8-K
caaxn
27 Feb 23
Other Events
8:00am
8-K
jzjmub0q
21 Feb 23
Other Events
8:00am
8-K
rq8chsz
2 Feb 23
Departure of Directors or Certain Officers
5:15pm
8-K
q0n ys2ys8dzh5w1859h
25 Jan 23
Other Events
8:00am
8-K
emf565
19 Jan 23
FDA Accepts Intercept’s New Drug Application for OCA for the Treatment of Pre-Cirrhotic Liver Fibrosis Due to NASH
8:05am
8-K
gxz8np7y8k6
17 Jan 23
Other Events
8:00am
8-K
cko5qis8r2fapewsag
11 Jan 23
Regulation FD Disclosure
8:00am
8-K
o2r6m1 arx7i835ltzdh
23 Dec 22
Regulation FD Disclosure
8:00am
8-K
d5li0z8je
1 Nov 22
Intercept Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
7:05am